Develops pills that help the body clear out harmful proteins.
New: first time
Duquesne bought Monte Rosa Therapeutics for the first time between April and June: 297,600 shares, worth about $7 million. That’s already less than $1 of every $100 they have in stocks.
Mar 31
None
Jun 30
297,600
The numbers
Shares they own
297,600
Value on Jun 30, 2026
$7,202,000
about $7 million
Share of their money
0.2%
less than $1 of every $100 · 73rd of 85
Price per share on Jun 30
$24.20
Kind
Shares
Also owned by
No other fund we follow
More about Monte Rosa Therapeutics ›
The value uses the price on Jun 30, 2026. The fund may have paid a different price.